Sun Pharma said the interim analysis did not meet the pre-specified primary endpoint of change in MDS-UPDRS Part III total score compared to placebo
Subscribe To Our Free Newsletter |
Sun Pharma said the interim analysis did not meet the pre-specified primary endpoint of change in MDS-UPDRS Part III total score compared to placebo
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!